1992-Planning for Chemicals, Pharmaceuticals and Biotechnology (eBook)
412 Seiten
Elsevier Science (Verlag)
978-1-4831-6175-4 (ISBN)
1992-Planning for Chemicals, Pharmaceuticals and Biotechnology provides a summary of the relevant legislation, research programs, and proposals for the establishment of a single European market for the chemical, pharmaceutical, and biotechnology industries. The development of the European Community's (EC) policy and the implications of its implementation for the EC and third country markets are discussed. The views from a number of major organizations that operate in the chemical, pharmaceutical, and biotechnology markets are considered to provide an insight into some of the factors influencing strategic planning for 1992. This book consists of 10 chapters and opens with an overview of the EC's goal of establishing a single market for the European Union by 1992, followed by a discussion on the implications of this single market for industry, commerce, and individuals. The following chapters focus on the Single European Act; corporate issues such as mergers and acquisitions; standards of good practice in the chemical, pharmaceutical, and biotechnology sectors; and implications of a single European market for these industries. The final chapter is devoted to the views of organizations in the chemical, pharmaceutical, and biotechnology sectors such as the European Chemical Industry Federation (CEFIC), Bayer AG, and COLIPA (European Cosmetic Industry Federation) in terms of the opportunities, problems, and challenges of the single European market. This monograph will be a useful resource for corporate managers, especially those in the IT sector, as well as policymakers and industry regulators.
Front Cover 1
1992-Planning for Chemicals, Pharmaceuticals and Biotechnology 4
Copyright Page 5
Table of Contents 6
ACKNOWLEDGEMENTS 12
FOREWORD 14
CHAPTER 1. INTRODUCTION 16
CHAPTER 2. THE SINGLE EUROPEAN MARKET 18
Achieving the internal market: 1957-1985 18
The Commission's White Paper proposals 20
Implications for industry, commerce and individuals 25
CHAPTER 3. THE SINGLE EUROPEAN ACT 30
Policy objectives 31
Reform of the decision-making process 33
Other institutional reforms 35
Problems envisaged in completing the internal market 36
The legislative process 37
CHAPTER 4. CORPORATE ISSUES 42
Background 42
Company law 42
Mergers and acquisitions 43
Mutual recognition of professional qualifications and employment rights 44
Corporate taxation 45
Transport 46
Public procurement 47
Intellectual property 48
Product liability 50
Community Research and Development programmes 51
CHAPTER 5. INDUSTRIAL AND FINE CHEMICALS 58
The chemical industry in the EC 58
Major industry sectors 60
Major issues affecting the industry 67
General chemicals - Existing legislation 72
General Chemicals - Proposed Legislation 81
Fertilisers - Existing legislation 83
Fertilisers - Proposed Legislation 84
Agrochemicals - Existing legislation 85
Agrochemicals - Proposed Legislation 89
Paints and adhesives - Existing legislation 93
Cosmetics and toiletries Existing legislation 94
Cosmetics and Toiletries - Proposed Legislation 103
Environment - Air - Existing legislation 104
Environment - Air - Proposed Legislation 112
Environment - Water - Existing Legislation 113
Environment - Water - Proposed Legislation 122
Environment - Waste - Existing Legislation 127
Environment - Waste - Proposed Legislation 135
Environment - Waste - Legislation Yet to be Proposed 138
Environment - Nuclear Waste - Existing Legislation 139
Environment - Chlorofluorocarbons - Existing Legislation 142
Environment general - Existing legislation 146
Environment - General - Proposed Legislation 148
CHAPTER 6. PHARMACEUTICALS 150
Pharmaceuticals in the EC 150
Medicinal products - Existing legislation 164
Testing of medicinal products Existing legislation 189
Additives to medicinal products Existing legislation 194
Pricing of medicinal products - Existing legislation 195
Medicinal products - Legislation yet to be proposed 201
Veterinary medicinal products - Existing legislation 201
Veterinary Medicinal Products - Proposed Legislation 213
Testing of Veterinary Medicinal products - Existing Legislation 218
Residues of veterinary medicinal products - Proposed legislation 219
Consumer protection - Existing legislation 222
Consumer Protection - Proposed Legislation 228
CHAPTER 7. BIOTECHNOLOGY 230
Biotechnology in the EC 230
Proposed legislation 237
CHAPTER 8. STANDARDS OF GOOD PRACTICE 250
Background 250
Health and safety 250
Good laboratory practice 250
Good manufacturing practice 250
Animal experimentation 251
Health and safety of workers Existing legislation 251
Health And Safety of Workers - Proposed Legislation 267
Good laboratory practice Existing legislation 297
Animal experimentation Existing legislation 299
CHAPTER 9. IMPLICATIONS OF A SINGLE EUROPEAN MARKET 304
Industrial and fine chemicals 304
Pharmaceuticals 312
Biotechnology 319
CHAPTER 10. STRATEGIC PLANNING FOR 1992 322
CURRENT DEVELOPMENTS IN THE EUROPEAN CHEMICAL INDUSTRY1 323
1992 AND THE CHEMICAL INDUSTRY: THE ROLE OF THE CHEMICAL INDUSTRIES ASSOCIATION 330
THE SINGLE MARKET FORCES ON THE CHEMICAL INDUSTRY 341
THE EUROPEAN FERTILISER MARKET 348
EUROPEAN REGISTRATION FOR AGROCHEMICALS 351
AGROCHEMICALS AND THE SINGLE MARKET6 356
A COMMUNITY POLICY FOR THE MEDICINES INDUSTRY 362
PROGRESS TOWARDS AN INTERNAL MARKET IN THE PHARMACEUTICAL SECTOR8 369
BAYER'S POSITION IN WORLD TRADE 376
THE INTERNAL MARKET - A CHALLENGE FOR THE PHARMACEUTICAL INDUSTRY: BENEFITS AND PROBLEMS 380
PLANT BIOTECHNOLOGY: NOVEL APPROACHES TO OLD PROBLEMS 388
THE COORDINATION OF POLICIES FOR BIOTECHNOLOGY IN EUROPE9 396
COMPLETION OF THE INTERNAL MARKET IN THE PERFUME, COSMETICS AND TOILETRIES SECTOR 405
| Erscheint lt. Verlag | 22.10.2013 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie |
| Recht / Steuern ► EU / Internationales Recht | |
| Recht / Steuern ► Öffentliches Recht | |
| ISBN-10 | 1-4831-6175-7 / 1483161757 |
| ISBN-13 | 978-1-4831-6175-4 / 9781483161754 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich